| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Article |
1 Department of Surgery, Academic Medical Center, P.O. Box 227001100 DE Amsterdam The Netherlands
2 Department of Gastroenterology, Academic Medical Center, P.O. Box 22700, 1100 DE Amsterdam The Netherlands
Correspondence: Address correspondence and reprint requests to: Thomas M. van Gulik, MD; E-mail: t.m.vangulik{at}amc.uva.nl
Background: Treatment of hilar cholangiocarcinoma (Klatskin tumors) has changed in many aspects. A more extensive surgical approach, as proposed by Japanese surgeons, has been applied in our center over the last 5 years; it combines hilar resection with partial hepatectomy for most tumors. The aim of this study was to assess the outcome of a 15-year evolution in the surgical treatment of Klatskin tumors.
Methods: A total of 99 consecutive patients underwent resection for hilar cholangiocarcinoma in three 5-year time periods: periods 1 (19881993; n = 45), 2 (19931998; n = 25), and 3 (19982003; n = 29). Outcome was evaluated by assessment of completeness of resection, postoperative morbidity and mortality, and survival.
Results: The proportion of margin negative resections increased significantly from 13% in period 1 to 59% in period 3 (P < .05). Two-year survival increased significantly from 33% ± 7% and 39% ± 10% in periods 1 and 2 to 60% ± 11% in period 3 (P < .05). Postoperative morbidity and mortality were considerable but did not increase with this changed surgical strategy (68% and 10%, respectively, in period 3). Lymph node metastasis was, next to period of resection, also associated with survival in univariate analysis.
Conclusions: Mainly in the last 5-year period (19982003), when the Japanese surgical approach was followed, more hilar resections were combined with partial liver resections that included segments 1 and 4, thus leading to more R0 resections. This, together with a decrease in lymph node metastases, resulted in improved survival without significantly affecting postoperative morbidity or mortality.
Key Words: Hilar cholangiocarcinoma Hepatectomy Liver Surgery Mortality Survival
This article has been cited by other articles:
![]() |
L. Yubin, F. Chihua, J. Zhixiang, O. Jinrui, L. Zixian, Z. Jianghua, L. Ye, J. Haosheng, and L. Chaomin Surgical Management and Prognostic Factors of Hilar Cholangiocarcinoma: Experience with 115 Cases in China Ann. Surg. Oncol., August 1, 2008; 15(8): 2113 - 2119. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. van Gulik and D. J. Gouma Changing Perspectives in the Assessment of Resectability of Hilar Cholangiocarcinoma Ann. Surg. Oncol., July 1, 2007; 14(7): 1969 - 1971. [Full Text] [PDF] |
||||
![]() |
S. Dinant, W. de Graaf, B. J. Verwer, R. J. Bennink, K. P. van Lienden, D. J. Gouma, A. K. van Vliet, and T. M. van Gulik Risk Assessment of Posthepatectomy Liver Failure Using Hepatobiliary Scintigraphy and CT Volumetry J. Nucl. Med., May 1, 2007; 48(5): 685 - 692. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |